nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.116	0.182	CbGbCtD
Glipizide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.116	0.182	CbGbCtD
Glipizide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0889	0.14	CbGbCtD
Glipizide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0878	0.138	CbGbCtD
Glipizide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.06	0.0945	CbGbCtD
Glipizide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0573	0.0902	CbGbCtD
Glipizide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.051	0.0804	CbGbCtD
Glipizide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.03	0.0472	CbGbCtD
Glipizide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0283	0.0445	CbGbCtD
Glipizide—Gliclazide—VEGFA—chronic obstructive pulmonary disease	0.00375	0.709	CrCbGaD
Glipizide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00351	0.0412	CbGpPWpGaD
Glipizide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00311	0.0364	CbGpPWpGaD
Glipizide—KCNJ11—Type II diabetes mellitus—ADIPOQ—chronic obstructive pulmonary disease	0.00292	0.0342	CbGpPWpGaD
Glipizide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00254	0.0298	CbGpPWpGaD
Glipizide—ABCC8—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00246	0.0289	CbGpPWpGaD
Glipizide—KCNJ11—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.00239	0.028	CbGpPWpGaD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.00216	0.0253	CbGpPWpGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—SFTPD—chronic obstructive pulmonary disease	0.00212	0.0249	CbGpPWpGaD
Glipizide—PPARG—Differentiation of white and brown adipocyte   —ADIPOQ—chronic obstructive pulmonary disease	0.00195	0.0228	CbGpPWpGaD
Glipizide—ABCC8—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00194	0.0227	CbGpPWpGaD
Glipizide—KCNJ11—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00188	0.022	CbGpPWpGaD
Glipizide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00176	0.0206	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00163	0.0191	CbGpPWpGaD
Glipizide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.0016	0.0187	CbGpPWpGaD
Glipizide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.0015	0.0176	CbGpPWpGaD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.00134	0.0157	CbGpPWpGaD
Glipizide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00129	0.0151	CbGpPWpGaD
Glipizide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00128	0.015	CbGpPWpGaD
Glipizide—PPARG—Differentiation of white and brown adipocyte   —LEP—chronic obstructive pulmonary disease	0.00121	0.0142	CbGpPWpGaD
Glipizide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00116	0.0136	CbGpPWpGaD
Glipizide—Gliclazide—ALB—chronic obstructive pulmonary disease	0.00101	0.191	CrCbGaD
Glipizide—PPARG—Regulation of retinoblastoma protein—TGFB2—chronic obstructive pulmonary disease	0.000995	0.0117	CbGpPWpGaD
Glipizide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000989	0.0116	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000876	0.0103	CbGpPWpGaD
Glipizide—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000876	0.00319	CcSEcCtD
Glipizide—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000876	0.00319	CcSEcCtD
Glipizide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000873	0.00318	CcSEcCtD
Glipizide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000872	0.00318	CcSEcCtD
Glipizide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000865	0.00315	CcSEcCtD
Glipizide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000865	0.00315	CcSEcCtD
Glipizide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000863	0.00315	CcSEcCtD
Glipizide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00086	0.00313	CcSEcCtD
Glipizide—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000859	0.00313	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—HDAC2—chronic obstructive pulmonary disease	0.000851	0.00997	CbGpPWpGaD
Glipizide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000849	0.00309	CcSEcCtD
Glipizide—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000844	0.00989	CbGpPWpGaD
Glipizide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000841	0.00985	CbGpPWpGaD
Glipizide—KCNJ11—Type II diabetes mellitus—TNF—chronic obstructive pulmonary disease	0.000839	0.00982	CbGpPWpGaD
Glipizide—Tension—Formoterol—chronic obstructive pulmonary disease	0.000837	0.00305	CcSEcCtD
Glipizide—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000837	0.00305	CcSEcCtD
Glipizide—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000831	0.00303	CcSEcCtD
Glipizide—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.00302	CcSEcCtD
Glipizide—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000829	0.00302	CcSEcCtD
Glipizide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000828	0.00302	CcSEcCtD
Glipizide—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000827	0.00301	CcSEcCtD
Glipizide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000821	0.00299	CcSEcCtD
Glipizide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000821	0.00299	CcSEcCtD
Glipizide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000816	0.00955	CbGpPWpGaD
Glipizide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000815	0.00297	CcSEcCtD
Glipizide—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000812	0.00951	CbGpPWpGaD
Glipizide—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00081	0.00295	CcSEcCtD
Glipizide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000806	0.00294	CcSEcCtD
Glipizide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000804	0.00293	CcSEcCtD
Glipizide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00291	CcSEcCtD
Glipizide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00291	CcSEcCtD
Glipizide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000796	0.0029	CcSEcCtD
Glipizide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000794	0.00289	CcSEcCtD
Glipizide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000792	0.00289	CcSEcCtD
Glipizide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000792	0.00289	CcSEcCtD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—chronic obstructive pulmonary disease	0.000792	0.00928	CbGpPWpGaD
Glipizide—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000791	0.00288	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000786	0.00287	CcSEcCtD
Glipizide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000783	0.00285	CcSEcCtD
Glipizide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000783	0.00285	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000781	0.00915	CbGpPWpGaD
Glipizide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000781	0.00284	CcSEcCtD
Glipizide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000775	0.00282	CcSEcCtD
Glipizide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000775	0.00282	CcSEcCtD
Glipizide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00077	0.0028	CcSEcCtD
Glipizide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00077	0.0028	CcSEcCtD
Glipizide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000766	0.00898	CbGpPWpGaD
Glipizide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00076	0.00277	CcSEcCtD
Glipizide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00275	CcSEcCtD
Glipizide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000748	0.00273	CcSEcCtD
Glipizide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000748	0.00272	CcSEcCtD
Glipizide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00272	CcSEcCtD
Glipizide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000738	0.00269	CcSEcCtD
Glipizide—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000737	0.00269	CcSEcCtD
Glipizide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000737	0.00269	CcSEcCtD
Glipizide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000727	0.00265	CcSEcCtD
Glipizide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000727	0.00265	CcSEcCtD
Glipizide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000727	0.00265	CcSEcCtD
Glipizide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.00265	CcSEcCtD
Glipizide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000727	0.00265	CcSEcCtD
Glipizide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.00265	CcSEcCtD
Glipizide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000724	0.00264	CcSEcCtD
Glipizide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000724	0.00264	CcSEcCtD
Glipizide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000724	0.00264	CcSEcCtD
Glipizide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000723	0.00264	CcSEcCtD
Glipizide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000723	0.00263	CcSEcCtD
Glipizide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000718	0.00262	CcSEcCtD
Glipizide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000718	0.00262	CcSEcCtD
Glipizide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000712	0.00259	CcSEcCtD
Glipizide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000712	0.00259	CcSEcCtD
Glipizide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000709	0.00258	CcSEcCtD
Glipizide—ABCC8—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000709	0.00831	CbGpPWpGaD
Glipizide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000708	0.00258	CcSEcCtD
Glipizide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000706	0.00257	CcSEcCtD
Glipizide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00254	CcSEcCtD
Glipizide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00254	CcSEcCtD
Glipizide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000696	0.00254	CcSEcCtD
Glipizide—KCNJ11—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000688	0.00806	CbGpPWpGaD
Glipizide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.0025	CcSEcCtD
Glipizide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000686	0.0025	CcSEcCtD
Glipizide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000686	0.0025	CcSEcCtD
Glipizide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000684	0.00249	CcSEcCtD
Glipizide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000682	0.00249	CcSEcCtD
Glipizide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000682	0.00249	CcSEcCtD
Glipizide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000678	0.00247	CcSEcCtD
Glipizide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000674	0.00246	CcSEcCtD
Glipizide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000668	0.00243	CcSEcCtD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000666	0.0078	CbGpPWpGaD
Glipizide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000658	0.0024	CcSEcCtD
Glipizide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000648	0.00236	CcSEcCtD
Glipizide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.00236	CcSEcCtD
Glipizide—PPARG—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000636	0.00745	CbGpPWpGaD
Glipizide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000636	0.00232	CcSEcCtD
Glipizide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00232	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000635	0.00231	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000635	0.00231	CcSEcCtD
Glipizide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00063	0.0023	CcSEcCtD
Glipizide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00063	0.0023	CcSEcCtD
Glipizide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00228	CcSEcCtD
Glipizide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000626	0.00228	CcSEcCtD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000623	0.0073	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000622	0.00227	CcSEcCtD
Glipizide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000621	0.00226	CcSEcCtD
Glipizide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000621	0.00226	CcSEcCtD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.00062	0.00726	CbGpPWpGaD
Glipizide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000619	0.00226	CcSEcCtD
Glipizide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000619	0.00226	CcSEcCtD
Glipizide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000617	0.00225	CcSEcCtD
Glipizide—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000614	0.00719	CbGpPWpGaD
Glipizide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.00223	CcSEcCtD
Glipizide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000613	0.00223	CcSEcCtD
Glipizide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000613	0.00223	CcSEcCtD
Glipizide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000611	0.00223	CcSEcCtD
Glipizide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000607	0.00221	CcSEcCtD
Glipizide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000606	0.0071	CbGpPWpGaD
Glipizide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000605	0.00221	CcSEcCtD
Glipizide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.00219	CcSEcCtD
Glipizide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000601	0.00219	CcSEcCtD
Glipizide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000601	0.00219	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00218	CcSEcCtD
Glipizide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00217	CcSEcCtD
Glipizide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00217	CcSEcCtD
Glipizide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00217	CcSEcCtD
Glipizide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00217	CcSEcCtD
Glipizide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000595	0.00217	CcSEcCtD
Glipizide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00215	CcSEcCtD
Glipizide—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00059	0.00691	CbGpPWpGaD
Glipizide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000589	0.00215	CcSEcCtD
Glipizide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.00214	CcSEcCtD
Glipizide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.00213	CcSEcCtD
Glipizide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000583	0.00213	CcSEcCtD
Glipizide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000582	0.00212	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.000581	0.0068	CbGpPWpGaD
Glipizide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00058	0.0068	CbGpPWpGaD
Glipizide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00211	CcSEcCtD
Glipizide—ABCC8—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000578	0.00677	CbGpPWpGaD
Glipizide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000577	0.0021	CcSEcCtD
Glipizide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000577	0.0021	CcSEcCtD
Glipizide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000575	0.00209	CcSEcCtD
Glipizide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000574	0.00209	CcSEcCtD
Glipizide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000574	0.00209	CcSEcCtD
Glipizide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000573	0.00209	CcSEcCtD
Glipizide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000572	0.00208	CcSEcCtD
Glipizide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.00208	CcSEcCtD
Glipizide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.00208	CcSEcCtD
Glipizide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00057	0.00208	CcSEcCtD
Glipizide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.00207	CcSEcCtD
Glipizide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00205	CcSEcCtD
Glipizide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000562	0.00205	CcSEcCtD
Glipizide—KCNJ11—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000561	0.00657	CbGpPWpGaD
Glipizide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000558	0.00203	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000558	0.00203	CcSEcCtD
Glipizide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000557	0.00652	CbGpPWpGaD
Glipizide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000553	0.00202	CcSEcCtD
Glipizide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000553	0.00202	CcSEcCtD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000552	0.00647	CbGpPWpGaD
Glipizide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000551	0.00201	CcSEcCtD
Glipizide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000551	0.00201	CcSEcCtD
Glipizide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000549	0.002	CcSEcCtD
Glipizide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00198	CcSEcCtD
Glipizide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000544	0.00198	CcSEcCtD
Glipizide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000544	0.00198	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.000542	0.00635	CbGpPWpGaD
Glipizide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00198	CcSEcCtD
Glipizide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000542	0.00197	CcSEcCtD
Glipizide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000541	0.00197	CcSEcCtD
Glipizide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000539	0.00197	CcSEcCtD
Glipizide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000538	0.00196	CcSEcCtD
Glipizide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000536	0.00627	CbGpPWpGaD
Glipizide—Glyburide—ALB—chronic obstructive pulmonary disease	0.00053	0.1	CrCbGaD
Glipizide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.0019	CcSEcCtD
Glipizide—PPARG—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000521	0.0061	CbGpPWpGaD
Glipizide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.00189	CcSEcCtD
Glipizide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000513	0.00187	CcSEcCtD
Glipizide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000513	0.00187	CcSEcCtD
Glipizide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000513	0.00187	CcSEcCtD
Glipizide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000512	0.00186	CcSEcCtD
Glipizide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000503	0.00183	CcSEcCtD
Glipizide—PPARG—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.0005	0.00586	CbGpPWpGaD
Glipizide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.00182	CcSEcCtD
Glipizide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0005	0.00182	CcSEcCtD
Glipizide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000493	0.0018	CcSEcCtD
Glipizide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000493	0.0018	CcSEcCtD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—LEP—chronic obstructive pulmonary disease	0.000492	0.00576	CbGpPWpGaD
Glipizide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000489	0.00178	CcSEcCtD
Glipizide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000485	0.00177	CcSEcCtD
Glipizide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000484	0.00567	CbGpPWpGaD
Glipizide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000483	0.00176	CcSEcCtD
Glipizide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00174	CcSEcCtD
Glipizide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00174	CcSEcCtD
Glipizide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000474	0.00173	CcSEcCtD
Glipizide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00172	CcSEcCtD
Glipizide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000467	0.0017	CcSEcCtD
Glipizide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.0017	CcSEcCtD
Glipizide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000464	0.00544	CbGpPWpGaD
Glipizide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000462	0.00168	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000462	0.00541	CbGpPWpGaD
Glipizide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00168	CcSEcCtD
Glipizide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00168	CcSEcCtD
Glipizide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000451	0.00164	CcSEcCtD
Glipizide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00164	CcSEcCtD
Glipizide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.00161	CcSEcCtD
Glipizide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000443	0.00161	CcSEcCtD
Glipizide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00044	0.00516	CbGpPWpGaD
Glipizide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.0016	CcSEcCtD
Glipizide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000439	0.0016	CcSEcCtD
Glipizide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000439	0.0016	CcSEcCtD
Glipizide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000439	0.0016	CcSEcCtD
Glipizide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00159	CcSEcCtD
Glipizide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00159	CcSEcCtD
Glipizide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00159	CcSEcCtD
Glipizide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00158	CcSEcCtD
Glipizide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00158	CcSEcCtD
Glipizide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00157	CcSEcCtD
Glipizide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00157	CcSEcCtD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000429	0.00503	CbGpPWpGaD
Glipizide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.00156	CcSEcCtD
Glipizide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00156	CcSEcCtD
Glipizide—PPARG—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000426	0.00499	CbGpPWpGaD
Glipizide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.00152	CcSEcCtD
Glipizide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000417	0.00488	CbGpPWpGaD
Glipizide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000417	0.00152	CcSEcCtD
Glipizide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000415	0.00151	CcSEcCtD
Glipizide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00151	CcSEcCtD
Glipizide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.00151	CcSEcCtD
Glipizide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00151	CcSEcCtD
Glipizide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000414	0.00151	CcSEcCtD
Glipizide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000414	0.00151	CcSEcCtD
Glipizide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.0015	CcSEcCtD
Glipizide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000406	0.00148	CcSEcCtD
Glipizide—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000406	0.00475	CbGpPWpGaD
Glipizide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000405	0.00148	CcSEcCtD
Glipizide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000405	0.00474	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.0004	0.00469	CbGpPWpGaD
Glipizide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.00145	CcSEcCtD
Glipizide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00142	CcSEcCtD
Glipizide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000389	0.00456	CbGpPWpGaD
Glipizide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000389	0.00142	CcSEcCtD
Glipizide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.00137	CcSEcCtD
Glipizide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.00135	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000367	0.0043	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000366	0.00429	CbGpPWpGaD
Glipizide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00133	CcSEcCtD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000364	0.00427	CbGpPWpGaD
Glipizide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00131	CcSEcCtD
Glipizide—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000359	0.0042	CbGpPWpGaD
Glipizide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000358	0.0013	CcSEcCtD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000351	0.00411	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000347	0.00406	CbGpPWpGaD
Glipizide—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000346	0.00405	CbGpPWpGaD
Glipizide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000345	0.00126	CcSEcCtD
Glipizide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000341	0.00124	CcSEcCtD
Glipizide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000339	0.00123	CcSEcCtD
Glipizide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000336	0.00122	CcSEcCtD
Glipizide—ABCC8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000334	0.00392	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APIP—chronic obstructive pulmonary disease	0.000324	0.0038	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000323	0.00379	CbGpPWpGaD
Glipizide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.00118	CcSEcCtD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000321	0.00376	CbGpPWpGaD
Glipizide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00115	CcSEcCtD
Glipizide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000312	0.00114	CcSEcCtD
Glipizide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.00113	CcSEcCtD
Glipizide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000303	0.0011	CcSEcCtD
Glipizide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000302	0.0011	CcSEcCtD
Glipizide—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000301	0.0011	CcSEcCtD
Glipizide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.00109	CcSEcCtD
Glipizide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00108	CcSEcCtD
Glipizide—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000295	0.00345	CbGpPWpGaD
Glipizide—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00106	CcSEcCtD
Glipizide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000287	0.00337	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000286	0.00335	CbGpPWpGaD
Glipizide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00104	CcSEcCtD
Glipizide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00104	CcSEcCtD
Glipizide—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00104	CcSEcCtD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00333	CbGpPWpGaD
Glipizide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000283	0.00103	CcSEcCtD
Glipizide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00101	CcSEcCtD
Glipizide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000999	CcSEcCtD
Glipizide—Shock—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000983	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000265	0.000966	CcSEcCtD
Glipizide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000952	CcSEcCtD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000255	0.00298	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000254	0.00297	CbGpPWpGaD
Glipizide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000251	0.00295	CbGpPWpGaD
Glipizide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00091	CcSEcCtD
Glipizide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.000909	CcSEcCtD
Glipizide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000903	CcSEcCtD
Glipizide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000897	CcSEcCtD
Glipizide—PPARG—Signaling events mediated by HDAC Class I—TNF—chronic obstructive pulmonary disease	0.000246	0.00288	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000244	0.00285	CbGpPWpGaD
Glipizide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000879	CcSEcCtD
Glipizide—PPARG—Metabolism—APIP—chronic obstructive pulmonary disease	0.00024	0.00281	CbGpPWpGaD
Glipizide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000868	CcSEcCtD
Glipizide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000867	CcSEcCtD
Glipizide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000866	CcSEcCtD
Glipizide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000237	0.00277	CbGpPWpGaD
Glipizide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000861	CcSEcCtD
Glipizide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000854	CcSEcCtD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000231	0.00271	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000228	0.00267	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000228	0.00267	CbGpPWpGaD
Glipizide—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000228	0.00267	CbGpPWpGaD
Glipizide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000823	CcSEcCtD
Glipizide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000817	CcSEcCtD
Glipizide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.000816	CcSEcCtD
Glipizide—ABCC8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000222	0.0026	CbGpPWpGaD
Glipizide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000794	CcSEcCtD
Glipizide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00079	CcSEcCtD
Glipizide—ABCC8—Metabolism—GC—chronic obstructive pulmonary disease	0.000216	0.00252	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000215	0.00252	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000213	0.00249	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GC—chronic obstructive pulmonary disease	0.000209	0.00245	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00243	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000207	0.00242	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000203	0.00238	CbGpPWpGaD
Glipizide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000736	CcSEcCtD
Glipizide—ABCC8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.0002	0.00235	CbGpPWpGaD
Glipizide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000717	CcSEcCtD
Glipizide—KCNJ11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000194	0.00228	CbGpPWpGaD
Glipizide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000707	CcSEcCtD
Glipizide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000683	CcSEcCtD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.0022	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000182	0.00213	CbGpPWpGaD
Glipizide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000661	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00018	0.0021	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000179	0.0021	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000179	0.0021	CbGpPWpGaD
Glipizide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000635	CcSEcCtD
Glipizide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00063	CcSEcCtD
Glipizide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000629	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000172	0.00201	CbGpPWpGaD
Glipizide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000626	CcSEcCtD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000171	0.002	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000168	0.00197	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.00194	CbGpPWpGaD
Glipizide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000593	CcSEcCtD
Glipizide—PPARG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.00016	0.00188	CbGpPWpGaD
Glipizide—PPARG—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000159	0.00186	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000157	0.00184	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GC—chronic obstructive pulmonary disease	0.000154	0.00181	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.00177	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.00015	0.00175	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00174	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000144	0.00168	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.0016	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000128	0.0015	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000126	0.00148	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000124	0.00146	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000121	0.00141	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00012	0.0014	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000118	0.00139	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000118	0.00138	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000116	0.00136	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000116	0.00136	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.00134	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000114	0.00134	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000114	0.00134	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000113	0.00132	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000111	0.0013	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00129	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00127	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000106	0.00124	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000103	0.00121	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000103	0.00121	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.96e-05	0.00117	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.82e-05	0.00115	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	9.79e-05	0.00115	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.78e-05	0.00115	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.49e-05	0.00111	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	9.31e-05	0.00109	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	9.27e-05	0.00109	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	9.12e-05	0.00107	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	8.83e-05	0.00103	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	8.52e-05	0.000998	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.44e-05	0.000988	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	8.34e-05	0.000977	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.31e-05	0.000973	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.19e-05	0.00096	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.16e-05	0.000956	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.05e-05	0.000943	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.91e-05	0.000927	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.8e-05	0.000914	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.78e-05	0.000911	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.63e-05	0.000894	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	7.61e-05	0.000892	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.53e-05	0.000882	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.5e-05	0.000879	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.27e-05	0.000852	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.24e-05	0.000848	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.14e-05	0.000836	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.11e-05	0.000833	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.01e-05	0.000821	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.89e-05	0.000808	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.68e-05	0.000783	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.29e-05	0.000737	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6e-05	0.000703	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.85e-05	0.000685	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.85e-05	0.000685	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.82e-05	0.000682	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.8e-05	0.000679	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.77e-05	0.000676	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	5.69e-05	0.000666	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.51e-05	0.000645	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.4e-05	0.000633	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.37e-05	0.00063	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.29e-05	0.000619	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.14e-05	0.000602	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.09e-05	0.000597	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALB—chronic obstructive pulmonary disease	4.83e-05	0.000566	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—chronic obstructive pulmonary disease	4.69e-05	0.000549	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.62e-05	0.000542	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NOS3—chronic obstructive pulmonary disease	4.48e-05	0.000525	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.46e-05	0.000523	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.000494	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.15e-05	0.000486	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.86e-05	0.000452	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.75e-05	0.000439	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.49e-05	0.000409	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	3.46e-05	0.000406	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	3.31e-05	0.000388	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.11e-05	0.000364	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.07e-05	0.00036	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.86e-05	0.000335	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.8e-05	0.000328	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.58e-05	0.000303	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.15e-05	0.000252	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.12e-05	0.000249	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.05e-05	0.00024	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.03e-05	0.000237	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.98e-05	0.000232	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.88e-05	0.00022	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.85e-05	0.000217	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.7e-05	0.0002	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.42e-05	0.000166	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.4e-05	0.000164	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000153	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000149	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000145	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.22e-05	0.000143	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.41e-06	9.85e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.05e-06	9.43e-05	CbGpPWpGaD
